174 related articles for article (PubMed ID: 23683948)
1. Induction chemotherapy for squamous cell head and neck cancer: a neverending story?
Benasso M
Oral Oncol; 2013 Aug; 49(8):747-52. PubMed ID: 23683948
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
Vermorken JB; Remenar E; van Herpen C; Gorlia T; Mesia R; Degardin M; Stewart JS; Jelic S; Betka J; Preiss JH; van den Weyngaert D; Awada A; Cupissol D; Kienzer HR; Rey A; Desaunois I; Bernier J; Lefebvre JL;
N Engl J Med; 2007 Oct; 357(17):1695-704. PubMed ID: 17960012
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel in the management of patients with head and neck squamous cell carcinoma.
Bernier J; Vrieling C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
Posner MR; Hershock DM; Blajman CR; Mickiewicz E; Winquist E; Gorbounova V; Tjulandin S; Shin DM; Cullen K; Ervin TJ; Murphy BA; Raez LE; Cohen RB; Spaulding M; Tishler RB; Roth B; Viroglio Rdel C; Venkatesan V; Romanov I; Agarwala S; Harter KW; Dugan M; Cmelak A; Markoe AM; Read PW; Steinbrenner L; Colevas AD; Norris CM; Haddad RI;
N Engl J Med; 2007 Oct; 357(17):1705-15. PubMed ID: 17960013
[TBL] [Abstract][Full Text] [Related]
5. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
6. Current concepts for the management of head and neck cancer: chemotherapy.
Specenier PM; Vermorken JB
Oral Oncol; 2009; 45(4-5):409-15. PubMed ID: 18715812
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
8. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
Bourhis J; Lefebvre JL; Vermorken JB
Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
10. The role of chemotherapy in the curative treatment of head and neck cancer.
Pfister DG; Shaha AR; Harrison LB
Surg Oncol Clin N Am; 1997 Oct; 6(4):749-68. PubMed ID: 9309092
[TBL] [Abstract][Full Text] [Related]
11. TPF: a rational choice for larynx preservation?
Calais G
Oncologist; 2010; 15 Suppl 3():19-24. PubMed ID: 21036885
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
13. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck.
Posner MR; Colevas AD; Tishler RB
Semin Oncol; 2000 Aug; 27(4 Suppl 8):13-24. PubMed ID: 10952434
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
Roman E; Raez LE; Santos ES
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy for head and neck cancer: recent data.
Vokes EE
Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of head and neck cancer].
Kohno N; Nakazawa E; Kusunoki M; Nishiya M
Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
[TBL] [Abstract][Full Text] [Related]
17. Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
Tishler RB; Posner MR; Norris CM; Mahadevan A; Sullivan C; Goguen L; Wirth LJ; Costello R; Case M; Stowell S; Sammartino D; Busse PM; Haddad RI
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1036-44. PubMed ID: 16682134
[TBL] [Abstract][Full Text] [Related]
18. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
Taguchi T; Tsukuda M
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
[TBL] [Abstract][Full Text] [Related]
19. A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck.
Buiret G; Combe C; Favrel V; Pommier P; Martin L; Ecochard R; Fayette J; Tartas S; Ramade A; Céruse P
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):430-7. PubMed ID: 19775831
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]